Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
doi: 10.1016/j.redox.2025.103543 76 RongYHuangLYiKChenHLiuSZhangWet al
Knowing how they compare helps patients and prescribers make informed choices about where to source compounded medications
Retatrutide (development code LY3437943 ) is a single synthetic peptide developed by Eli Lilly that acts as a triple agonist at three receptors simultaneously: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor
Choose between two options: four or ten weekly injections that can jump-start your weight loss journey
The figures widely used are derived from animal research and accumulated community experience
US$ 22.71
US$ 29.58
US$ 20.41
